Hope for Brain Cancer
Posted: December 9, 2010 2:35 AM PST
A major discovery made in Montreal could soon afford to treat brain tumors. Angiotech The company recently signed a deal worth $ 35 million with the U.S. company Geron for the final study in humans.
The drug created by Dr. Richard Béliveau and his team allows the anti-cancer pass through the barrier of the brain. Until now, all chemotherapy treatments were unable to deal effectively with brain tumors.
"It's something major," enthuses Dr. Béliveau. During the toxicity tests conducted in the United States to a hundred patients, we even noticed two complete remissions. "You never see that in oncology," says the Chair in Cancer Prevention and Treatment of UQAM is also an author well known for his book The food against cancer.
For other diseases?
One who has dedicated his career to the battle against cancer says the drug could be used for other diseases. "It's a kind of molecular Trojan horse that hides the medication until he goes to the brain. That could apply for diseases like Alzheimer's, Parkinson's, anything that affects the brain, "explains the man who writes a weekly column in the Journal.
Normally, the barrier "blood-brain 'acts as a natural defense against plant phytochemicals that could be very harmful.
However, they also block chemotherapy that does not reach the brain. The drug developed by Angiotech can carry to the brain Taxol chemotherapy to kill cancer cells. "Right now, for death, the diagnosis of tumor is ten months is the same as fifty years ago. It is therefore a major breakthrough for brain tumors and other diseases, "says Dr. Beliveau. The latter is particularly proud to see that a molecule created at 100% in Montreal will now be tested throughout the United States for eventual commercialization.
Clinical trials take place in the largest U.S. cancer centers like MD Anderson Cancer Center in Houston and the Dana-Farber Cancer Institute in Boston.
* The agreement between Geron and Angiotech gives an exclusive international license.
Brain cancer in Brief
* It is estimated that by 2010 there will be 2,600 new cases of brain cancer in Canada
* Brain tumors are the leading cause of cancer death among children in countries
* An estimated 55,000 Canadians survive a brain tumor. Approximately 10,000 more are diagnosed annually with brain tumors
Sources: Canadian Foundation for brain tumors and the Canadian Cancer Society.
The 10 signs to identify the disease
Posted: 08 Dec 2010 11:37 PM PST
1. Immediate memory
The person with Alzheimer's disease systematically forgets recent events occur.
2. Familiar tasks
Alzheimer's disease affects the patient's ability to perform familiar tasks, however basic, like making his bed.
3. Language disorders
The patient tends to lose the use of common words to replace them with incongruous words that make her sentences incomprehensible.
4. Loss of sense of direction
one who suffers from Alzheimer's disease is lost very easily, even in places he knows. He does not remember where he lives.
5. Do not know choose
The Alzheimer's patient can no longer exercise his trial. It's hard to make choices and opted for solutions often inconsistent or contradictory.
6. No longer understand abstract things
whether invoices, calendars or any other type of numbering, the patient experiences great difficulty in adapting to abstract things.
7. Permanent disorder
The Alzheimer's patient can no longer store. Its own affairs are in permanent disorder.
8. Inconstancy and moodiness
The Alzheimer's patient can change the mood in the blink of an eye. It goes from sweetness to anger without any apparent reason.
9. Personality Disorders
A personality that was very welcoming and social may become withdrawn and suspicious, expressing feelings of fear or loneliness, and sometimes vice versa.
10. Lack of interest
The Alzheimer's patient loses all interest in undertaking activities that held him until then to heart. It becomes passive and looks around him as he drives.